Cerebrospinal fluid biomarkers and cognitive status in differential diagnosis of frontotemporal dementia and Alzheimer’s disease

OBJECTIVE: This study aimed to determine the most appropriate cognitive and cerebrospinal fluid (CSF) biomarker setting to distinguish frontotemporal dementia (FTD) from Alzheimer’s disease (AD). METHOD: Patients with FTD, those with AD, and those without dementia were enrolled in this study. CSF am...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Int Med Res
Autors principals: Casoli, Tiziana, Paolini, Susy, Fabbietti, Paolo, Fattoretti, Patrizia, Paciaroni, Lucia, Fabi, Katia, Gobbi, Beatrice, Galeazzi, Roberta, Rossi, Roberto, Lattanzio, Fabrizia, Pelliccioni, Giuseppe
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2019
Matèries:
Clinical Research Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6833432/
https://ncbi.nlm.nih.gov/pubmed/31524025
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0300060519860951
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars